Williamson Robert F III 4
4 · Perspective Therapeutics, Inc. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
Williamson Robert F III
Director
Transactions
- Purchase
Common Stock
2025-03-28$2.27/sh+22,192$50,376→ 70,837 total - Purchase
Common Stock
2025-03-31$2.14/sh+38,145$81,775→ 108,982 total
Holdings
- 366(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.1697, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.